North America Bioproduction Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), and End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others)

No. of Pages: 95    |    Report Code: BMIRE00030058    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Bioproduction Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Bioproduction Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Bioproduction Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Adoption of Regenerative Medicines
  • 5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Market Opportunities
  • 5.2.1 Patent Expiry of Blockbuster Biologics
5.3 Future Trends
  • 5.3.1 Shift Toward Automated Cell Therapy Manufacturing
5.4 Impact of Drivers and Restraints

6. North America Bioproduction Market Regional Analysis

6.1 North America Bioproduction Market Overview
6.2 North America Bioproduction Market Revenue 2020-2030 (US$ Million)
6.3 North America Bioproduction Market Forecast Analysis

7. North America Bioproduction Market Analysis – by Product

7.1 Biologics and Biosimilars
  • 7.1.1 Overview
  • 7.1.2 Biologics and Biosimilars: North America Bioproduction Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Vaccines
  • 7.2.1 Overview
  • 7.2.2 Vaccines: North America Bioproduction Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Cell and Gene Therapies
  • 7.3.1 Overview
  • 7.3.2 Cell and Gene Therapies: North America Bioproduction Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Nucleic Acid Therapeutics
  • 7.4.1 Overview
  • 7.4.2 Nucleic Acid Therapeutics: North America Bioproduction Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Bioproduction Market Analysis – by Application

8.1 Rheumatoid Arthritis
  • 8.1.1 Overview
  • 8.1.2 Rheumatoid Arthritis: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Hematological Disorders
  • 8.2.1 Overview
  • 8.2.2 Hematological Disorders: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Cancer
  • 8.3.1 Overview
  • 8.3.2 Cancer: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Diabetes
  • 8.4.1 Overview
  • 8.4.2 Diabetes: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Cardiovascular Diseases
  • 8.5.1 Overview
  • 8.5.2 Cardiovascular Diseases: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Bioproduction Market Analysis – by Equipment

9.1 Upstream Equipment
  • 9.1.1 Overview
  • 9.1.2 Cardiovascular Diseases: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Downstream Equipment
  • 9.2.1 Overview
  • 9.2.2 Cardiovascular Diseases: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Bioreactors
  • 9.3.1 Overview
  • 9.3.2 Cardiovascular Diseases: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Consumables and Accessories
  • 9.4.1 Overview
  • 9.4.2 Cardiovascular Diseases: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Bioproduction Market – North America Analysis

10.1 North America
  • 10.1.1 North America Bioproduction Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 North America Bioproduction Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 US: North America Bioproduction Market Breakdown, by Product
    • 10.1.1.1.2 US: North America Bioproduction Market Breakdown, by Application
    • 10.1.1.1.3 US: North America Bioproduction Market Breakdown, by Equipment
  • 10.1.1.2 Canada: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Canada: North America Bioproduction Market Breakdown, by Product
    • 10.1.1.2.2 Canada: North America Bioproduction Market Breakdown, by Application
    • 10.1.1.2.3 Canada: North America Bioproduction Market Breakdown, by Equipment
  • 10.1.1.3 Mexico : North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Bioproduction Market Breakdown, by Product
    • 10.1.1.3.2 Mexico : North America Bioproduction Market Breakdown, by Application
    • 10.1.1.3.3 Mexico : North America Bioproduction Market Breakdown, by Equipment

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Bioproduction Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Bio-Rad Laboratories Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Danaher Corp
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Lonza Group AG
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Merck KGaA
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Sartorius AG
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Thermo Fisher Scientific Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Bioproduction Market

1. Bio-Rad Laboratories Inc

2. Danaher Corp

3. F. Hoffmann-La Roche Ltd

4. Lonza Group AG

5. Merck KGaA

6. Sartorius AG

7. Thermo Fisher Scientific Inc

 

north-america-bioproduction-market